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The two antimicrobial peptides PGLa and magainin 2 (MAG2), both found in the skin of the 
African frog Xenopus laevis, are known to exhibit strong synergistic effects in bacterial 
killing, vesicle leakage and other membrane-related activities [1]. Here, we studied the 
synergy of the two peptides in an attempt to find the molecular mechanism behind the 
synergistic effect. A large number of mutants of the two peptides were investigated and the 
synergy tested using three complementary methods: (i) From a checkerboard assay, fractional 
inhibitory concentrations (FICs) were determined against two bacteria [2]. (ii) From a vesicle 
leakage assay, the increase in leakage of a 1:1 mixture of the two peptides compared to 
leakage of each peptide alone, showed the synergy effect in two different lipid systems [3]. 
(iii) From 15N-NMR, the insertion of PGLa to a transmembrane orientation (suggesting the 
formation of a pore) in the presence of MAG2 was investigated; without MAG2 this 
transmembrane orientation is not obtained and thus this orientation indicates synergy [4]. It 
was possible to identify mutations reducing or inhibiting the synergy of the peptides, and a 
single amino acid mutation of PGLa was enough to completely abolish synergy. On the other 
hand, a previously non-synergistic peptide could by mutations of two amino acids be 
modified to show strong synergy with MAG2. From these results a model of the peptide-
peptide complex in the membrane, likely responsible for synergy, could be developed and will 
be presented. 
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